| Highland Clinic Of Northwest Indiana Inc | |
|
2834 Highway Ave Ste 1 Highland IN 46322 | |
| (219) 838-0066 | |
| (219) 838-4096 |
| Full Name | Highland Clinic Of Northwest Indiana Inc |
|---|---|
| Speciality | General Practice |
| Location | 2834 Highway Ave Ste 1, Highland, Indiana |
| Authorized Official Name and Position | Nazeerulla Shaik (PHYSICIAN) |
| Authorized Official Contact | 2198380066 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Highland Clinic Of Northwest Indiana Inc 2834 Highway Ave Ste 1 Highland IN 46322-1629 Ph: (219) 838-0066 | Highland Clinic Of Northwest Indiana Inc 2834 Highway Ave Ste 1 Highland IN 46322 Ph: (219) 838-0066 |
| NPI Number | 1497954390 |
|---|---|
| Provider Enumeration Date | 07/12/2007 |
| Last Update Date | 12/10/2018 |
| Medicare PECOS PAC ID | 7214968213 |
|---|---|
| Medicare Enrollment ID | O20050830000400 |
News Archive
Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in "Nature Immunology."
A leading psychology professor at The University of Texas at Arlington has focused international attention on how a chronic pain patient's irrational doubts about never getting better can influence both his reactions to pain and even treatment outcomes.
A review of the published literature indicates that erectile dysfunction is common in males with diabetes, affecting more than half of men with the condition and with a prevalence of approximately 3.6-times higher than in non-diabetics.
Advanced imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI) might shorten the length of a person's hospital stay and decrease the high costs associated with hospitalization if used early, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
› Verified 3 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497954390 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 010226043 (Indiana) | Primary |
| Provider Name | Nkechi Onyeukwu |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1023031978 PECOS PAC ID: 5890697726 Enrollment ID: I20100723000349 |
News Archive
Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in "Nature Immunology."
A leading psychology professor at The University of Texas at Arlington has focused international attention on how a chronic pain patient's irrational doubts about never getting better can influence both his reactions to pain and even treatment outcomes.
A review of the published literature indicates that erectile dysfunction is common in males with diabetes, affecting more than half of men with the condition and with a prevalence of approximately 3.6-times higher than in non-diabetics.
Advanced imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI) might shorten the length of a person's hospital stay and decrease the high costs associated with hospitalization if used early, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
› Verified 3 days ago
| Provider Name | Nazeer U Shaik |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1295813996 PECOS PAC ID: 4486635497 Enrollment ID: I20141027000316 |
News Archive
Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in "Nature Immunology."
A leading psychology professor at The University of Texas at Arlington has focused international attention on how a chronic pain patient's irrational doubts about never getting better can influence both his reactions to pain and even treatment outcomes.
A review of the published literature indicates that erectile dysfunction is common in males with diabetes, affecting more than half of men with the condition and with a prevalence of approximately 3.6-times higher than in non-diabetics.
Advanced imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI) might shorten the length of a person's hospital stay and decrease the high costs associated with hospitalization if used early, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
› Verified 3 days ago
News Archive
Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in "Nature Immunology."
A leading psychology professor at The University of Texas at Arlington has focused international attention on how a chronic pain patient's irrational doubts about never getting better can influence both his reactions to pain and even treatment outcomes.
A review of the published literature indicates that erectile dysfunction is common in males with diabetes, affecting more than half of men with the condition and with a prevalence of approximately 3.6-times higher than in non-diabetics.
Advanced imaging techniques such as computed tomography (CT) scans and magnetic resonance imaging (MRI) might shorten the length of a person's hospital stay and decrease the high costs associated with hospitalization if used early, according to a study in the April issue of the Journal of the American College of Radiology (www.jacr.org).
Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.
› Verified 3 days ago
Dr Mary Tilak P C Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2241 45th St, Highland, IN 46322 Phone: 219-922-8051 Fax: 219-922-8608 | |
Family Health & Wellness Centre Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 8141 Kennedy Avenue, Highland, IN 46322 Phone: 219-838-5040 | |
219 Health Network, Inc. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 3100 45th St, Highland, IN 46322 Phone: 219-922-6911 Fax: 219-922-6968 | |
Highland Medical Center, Pc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9006 Indianapolis Blvd, Highland, IN 46322 Phone: 219-923-2241 | |
Infectious Disease Specialists, P.c. Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9143 Indianapolis Blvd, Highland, IN 46322 Phone: 219-972-1547 Fax: 219-836-0034 | |
Medical Associates Of Highland Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 9696 Gordon Dr, Highland, IN 46322 Phone: 219-937-2511 Fax: 219-937-2522 | |
Trucare Medical Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 8437 Kennedy Ave, Highland, IN 46322 Phone: 219-662-3931 Fax: 219-663-6359 |